Fever Tree Investor Relations and Funding

Fever Tree, a leading premium mixer brand, has received significant funding from investors to support its growth.

Fever Tree has received £100 million in funding from investors, including a £60 million investment from private equity firm, Carlyle Group.

This funding has enabled Fever Tree to expand its global presence and increase its production capacity.

Fever Tree has used its funding to invest in new production facilities and equipment, allowing for increased production and improved efficiency.

Fever-Tree has raised a total funding of $71.6M over 2 rounds.

Its first funding round was on March 12, 2013.

Fever-Tree has 2 institutional investors including LDC and Molson Coors.

Kevin Havelock is the only Angel Investor in Fever-Tree.

The latest funding round was a Post IPO round on February 3, 2025, for $88M.

Molson Coors participated in this latest round.

Here's a breakdown of Fever-Tree's recent funding rounds:

Fever-Tree has received funding from notable investors, with Molson Coors investing in the company's post-IPO round in 2025, providing $88M in funding.

Molson Coors' investment is a significant one, valuing Fever-Tree at 5,566,988 post-money.

LDC, another investor, provided $71.6M in funding in 2013, as part of a private equity round.

Fever-Tree has raised a total funding of $71.6M over 2 rounds. Its first funding round was on March 12, 2013.

Fever-Tree's latest funding round was a Post IPO round on February 3, 2025, for $88M. This round was participated by only one investor, Molson Coors.

Fever-Tree has a total of 3 institutional investors, including LDC, The Independent Investment Trust, and Molson Coors. Kevin Havelock is the only Angel Investor in Fever-Tree.

Here's a list of Fever-Tree's recent funding rounds:

Fevertree Drinks PLC has carved out a niche in the competitive drinks market by offering high-quality mixers that complement premium spirits.

Established in 2005, the company recognized a void in the market for premium mixers and has since become a vital partner to gin distillers.

Fevertree's revenue model revolves around premiumization and strategic partnerships, positioning its mixers as luxury goods priced higher than mainstream alternatives.

This dual-channel approach ensures wide accessibility and consistent brand visibility, with a presence in both on-trade channels, such as bars and restaurants, and off-trade channels, like retail stores.

Fevertree's strong export focus has mitigated risks associated with domestic market fluctuations, with a significant portion of its sales coming from international markets, particularly in Europe and North America.

The company's commitment to quality, coupled with strategic marketing, underpins its success and growth trajectory in the global beverage industry.

Fevertree's financial strength is a result of its ability to maintain substantial profit margins due to its premium pricing strategy.

The company's distribution model contributes to its financial strength, allowing it to maintain a strong presence in both on-trade and off-trade channels.

As an investor, it's essential to understand a company's financial health. Fevertree Drinks PLC's balance sheet reveals a healthy current ratio of 4.11, indicating that the company can cover its short-term debts easily.

Their current assets total 208.3 million, with a significant portion of that being cash and short-term investments at 65.9 million. This shows the company has a solid foundation for managing its finances.

Fevertree's solvency score is a reassuring 87/100, indicating the company is well-equipped to meet its long-term obligations.

Here's a breakdown of Fevertree's current liabilities and non-current liabilities:

Fevertree's manageable debt levels and robust financial position make it an attractive investment opportunity.

Fevertree Drinks PLC's financial performance is quite impressive. Their revenue for the period was a significant 361.7 million GBP.

The company's cost of revenue was substantial, at -236.5 million GBP, which is a major expense for any business. However, this is a normal part of operating a business that involves selling products.

Fevertree's gross profit was a respectable 125.2 million GBP, which is the difference between revenue and cost of revenue. This is a good sign that the company is able to sell its products at a price that covers its costs.

Operating expenses were a significant -96.1 million GBP, which is a major expense for the company. This includes costs such as salaries, rent, and other operational costs.

Fevertree's operating income was 29.1 million GBP, which is the profit made from the company's operations before interest and taxes. This is a good sign that the company is able to generate profit from its core business.

Here is a breakdown of Fevertree's financial performance:

Fevertree's profitability score is 53/100, which indicates that the company is not very profitable. However, this score can be influenced by various factors, and it's essential to consider other aspects of the company's financial performance.

Fevertree Drinks PLC's financial scores give us a snapshot of the company's health.

The company's profitability score is 53/100, which suggests that Fevertree Drinks PLC is not very profitable.

This score is a result of the company's profitability due diligence, which evaluates various aspects of the company's financial performance.

The higher the profitability score, the more profitable the company is.

Fevertree Drinks PLC's solvency score is 87/100, indicating that the company is very solvent.

This score is a result of the company's solvency due diligence, which assesses the company's ability to meet its financial obligations.

The higher the solvency score, the more solvent the company is.

Wall Street analysts predict an average 1-year price target for FEVR of 908.55 GBX. This forecast is based on a comprehensive analysis of the company's performance and growth prospects.

The low forecast for FEVR is 656.5 GBX, which indicates a potential downside risk for investors.

The high forecast of 1,391.25 GBX suggests a significant upside potential for investors who are optimistic about the company's future.

The intrinsic value of one FEVR stock under the Base Case scenario is 900.68 GBX, which serves as a benchmark for investors to evaluate the company's worth.